Fulvestrant for advanced breast cancer: a meta-analysis.
about
Fulvestrant for hormone-sensitive metastatic breast cancerEndocrine resistance in breast cancer--An overview and update.Hormone receptor positive, HER2 negative metastatic breast cancer: Future treatment landscape.Enhancing Endocrine Therapy Combination Strategies for the Treatment of Postmenopausal HR+/HER2- Advanced Breast Cancer.Efficacy and safety of endocrine monotherapy as first-line treatment for hormone-sensitive advanced breast cancer: A network meta-analysis.
P2860
Fulvestrant for advanced breast cancer: a meta-analysis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Fulvestrant for advanced breast cancer: a meta-analysis.
@en
type
label
Fulvestrant for advanced breast cancer: a meta-analysis.
@en
prefLabel
Fulvestrant for advanced breast cancer: a meta-analysis.
@en
P2093
P50
P1476
Fulvestrant for advanced breast cancer: a meta-analysis.
@en
P2093
Bostjan Seruga
Francisco Vera-Badillo
Mustafa Al-Mubarak
P304
P356
10.1016/J.CTRV.2013.03.004
P577
2013-06-10T00:00:00Z